Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
378 USD | -0.08% |
|
+0.81% | -0.15% |
17/06 | Wedbush Adjusts Price Target on argenx to $519 From $521, Maintains Outperform Rating | MT |
13/06 | Pliant Therapeutics, Inc. Appoints Steve Krognes to Its Board of Directors | CI |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ARGX Stock
- ARGX Stock
- Charts argenx SE